AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BioLargo, Inc.

$0.1 -$0.09 (-46.75%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.1
Day Range
$0.1$0.1
Year Range
$0.08$0.23
Market Cap
32.09M
AVG Volume
466.09K
Trailing/Forward PE
-2.21/-
PEG ratio
0.06
Dividend Yield
-
Next Earnings Date
2026-11-18
Primary Exchange
Other OTCUS
Revenue (USD)
05M10M15M20M2016201720182019202020212022202320242025
BLGO Revenue (USD) by year
PeriodRevenue (USD)
20257.76M
202417.78M
202312.23M
20225.89M
20212.54M
20202.43M
20191.86M
20181.36M
2017516.21K
2016281.11K
Net Income (USD)
-15M-10M-5M02016201720182019202020212022202320242025
BLGO Net Income (USD) by year
PeriodNet Income (USD)
2025-11.78M
2024-2.4M
2023-3.5M
2022-4.52M
2021-7.08M
2020-8.43M
2019-10.69M
2018-10.22M
2017-8.8M
2016-7.84M
Operating Income (USD)
-15M-10M-5M02016201720182019202020212022202320242025
BLGO Operating Income (USD) by year
PeriodOperating Income (USD)
2025-14.84M
2024-4.33M
2023-4.16M
2022-5.16M
2021-6.44M
2020-7.58M
2019-6.7M
2018-6.41M
2017-5.9M
2016-4.93M
EBITDA (USD)
-15M-10M-5M02016201720182019202020212022202320242025
BLGO EBITDA (USD) by year
PeriodEBITDA (USD)
2025-14.55M
2024-4M
2023-4.26M
2022-5.03M
2021-6.65M
2020-7.73M
2019-7.38M
2018-7.15M
2017-5.75M
2016-5.01M
Cash Flows (USD)
-10M-7.5M-5M-2.5M02016201720182019202020212022202320242025
BLGO Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-8.34M
2024-4.44M
2023-2.84M
2022-3.03M
2021-3.97M
2020-4.18M
2019-4.46M
2018-3.95M
2017-4.31M
2016-3.78M
EPS (USD)
-0.1-0.08-0.05-0.03-02016201720182019202020212022202320242025
BLGO EPS (USD) by year
PeriodEPS (USD)
2025-0.04
2024-0.01
2023-0.01
2022-0.02
2021-0.03
2020-0.04
2019-0.07
2018-0.08
2017-0.09
2016-0.09
Expenses (USD)
05M10M15MR&DSG&ACapex2016201720182019202020212022202320242025
BLGO Expenses (USD) by year
PeriodExpenses (USD)
202514.37M
202413.42M
202310.79M
20228.33M
20217.58M
20208.84M
20197.64M
20187.04M
20176.09M
20165.16M
Cash & Debt (USD)
02M4M6MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
BLGO Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20253.88M
20243.55M
20233.54M
20221.85M
2021962K
2020716K
2019655K
2018655K
2017990.46K
20161.91M
Debt ratios
-0.2-0.100.120182019202020212022202320242025
BLGO Debt ratios by year
PeriodDebt ratios
20250.01
20240.05
20230.08
20220.01
2021-0.01
2020-0.07
2019-0.15
2018-0.11
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
BLGO Margins by year
PeriodMargins
202543.86%
202444.17%
202350.3%
202248.61%
202143.63%
202050.47%
201949.22%
201845.53%
201737.48%
201662.34%
Return on Capital
-2000%0%2000%4000%2016201720182019202020212022202320242025
BLGO Return on Capital by year
PeriodReturn on Capital
2025-771.89%
2024-39.66%
2023-83.39%
2022-224.81%
2021-758.84%
20203588.09%
2019490.23%
2018910.15%
2017257.96%
20161017.89%
Shares Outstanding
0100M200M300M400M2016201720182019202020212022202320242025
BLGO Shares Outstanding by year
PeriodShares Outstanding
2025306.95M
2024301.27M
2023291.4M
2022276.35M
2021252.91M
2020233.73M
2019163.63M
2018142.25M
2017102.73M
201691.32M
Book Value Per Share (USD)
-0.04-0.0200.020.042016201720182019202020212022202320242025
BLGO Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20250
20240.02
20230.01
20220.01
20210
2020-0
2019-0.01
2018-0.01
2017-0.03
2016-0.01
Total Assets (USD)
05M10M15M2016201720182019202020212022202320242025
BLGO Total Assets (USD) by year
PeriodTotal Assets (USD)
20258.31M
202410.51M
20238.21M
20224.86M
20213.02M
20204.94M
20193.62M
20183.19M
20171.5M
20162.11M
Employee Count
02040602016201720182019202020212022202320242025
BLGO Employee Count by year
PeriodEmployee Count
202544
202440
202331
202232
202127
202027
201925
201825
201729
201619
Free Cash Flow Yield
-40%-30%-20%-10%0%med -14.16%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BLGO Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-33.55%
Sep 26-32.71%
Sep 26-36.92%
Aug 26-31.67%
Aug 26-33.2%
Aug 26-31.06%
Aug 26-26.99%
Jul 26-28.55%
Jul 26-26.37%
Jul 26-27.46%
Jul 26-25.93%
Jul 26-26.87%
Jun 26-26.27%
Jun 26-26.99%
Jun 26-24.74%
Jun 26-25.82%
May 26-22.86%
May 26-19.93%
May 26-22.39%
May 26-17.93%
May 26-17.8%
Apr 26-17.92%
Apr 26-18.62%
Apr 26-18.9%
Apr 26-18.18%
Mar 26-16.6%
Mar 26-16.32%
Mar 26-16.04%
Mar 26-16.36%
Feb 26-15.65%
Feb 26-16.47%
Feb 26-16.68%
Feb 26-15.87%
Jan 26-15.61%
Jan 26-15.1%
Jan 26-14.75%
Jan 26-14.34%
Jan 26-14.87%
Dec 25-15.94%
Dec 25-15.37%
Dec 25-15.95%
Dec 25-14.71%
Nov 25-15.34%
Nov 25-18.41%
Nov 25-17.85%
Nov 25-13.56%
Oct 25-15.81%
Oct 25-14.99%
Oct 25-14.99%
Oct 25-15.47%
Oct 25-14.96%
Sep 25-13.78%
Sep 25-12.25%
Sep 25-11.56%
Sep 25-11.29%
Aug 25-11.3%
Aug 25-12.49%
Aug 25-13.97%
Aug 25-11.64%
Aug 25-10.87%
Jul 25-10.33%
Jul 25-10.29%
Jul 25-9.75%
Jul 25-9.82%
Jun 25-9.97%
Jun 25-9.52%
Jun 25-9.77%
Jun 25-8.88%
May 25-9.16%
May 25-8.97%
May 25-9.1%
May 25-6.18%
May 25-6.63%
Apr 25-6.23%
Apr 25-6.35%
Apr 25-6.3%
Apr 25-5.87%
Mar 25-3.18%
Mar 25-3.1%
Mar 25-3.41%
Mar 25-3.4%
Feb 25-3.39%
Feb 25-3.39%
Feb 25-3.52%
Feb 25-3.33%
Jan 25-3.54%
Jan 25-3.56%
Jan 25-3.12%
Jan 25-3.01%
Jan 25-3.62%
Dec 24-4.49%
Dec 24-4.6%
Dec 24-4.6%
Dec 24-4.6%
Nov 24-4.55%
Nov 24-5%
Nov 24-4.93%
Nov 24-3.77%
Nov 24-3.2%
Oct 24-3%
Price to Sales
246810med 4.53Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BLGO Price to Sales by year
PeriodPrice to Sales
Sep 267.57
Sep 267.77
Sep 266.88
Aug 268.02
Aug 267.65
Aug 268.18
Aug 266.25
Jul 265.91
Jul 266.39
Jul 266.14
Jul 266.5
Jul 266.28
Jun 266.42
Jun 266.25
Jun 266.82
Jun 266.53
May 267.38
May 268.46
May 267.53
May 265.99
May 266.04
Apr 266
Apr 265.77
Apr 265.68
Apr 265.91
Mar 266.47
Mar 266.58
Mar 266.7
Mar 266.57
Feb 265.1
Feb 264.85
Feb 264.79
Feb 265.03
Jan 265.12
Jan 265.29
Jan 265.42
Jan 265.57
Jan 265.37
Dec 255.01
Dec 255.2
Dec 255.01
Dec 255.43
Nov 255.21
Nov 254.34
Nov 254.48
Nov 253.93
Oct 253.37
Oct 253.56
Oct 253.56
Oct 253.45
Oct 253.57
Sep 253.87
Sep 254.36
Sep 254.62
Sep 254.72
Aug 254.72
Aug 254.27
Aug 253.82
Aug 253.11
Aug 253.33
Jul 253.5
Jul 253.51
Jul 253.71
Jul 253.68
Jun 253.62
Jun 253.8
Jun 253.7
Jun 254.07
May 253.95
May 254.03
May 253.97
May 254.04
May 253.77
Apr 254.01
Apr 253.93
Apr 253.96
Apr 254.26
Mar 254.59
Mar 254.71
Mar 254.27
Mar 254.29
Feb 254.3
Feb 254.3
Feb 254.14
Feb 254.39
Jan 254.12
Jan 254.1
Jan 254.67
Jan 254.85
Jan 254.03
Dec 243.25
Dec 243.17
Dec 243.17
Dec 243.17
Nov 243.21
Nov 242.91
Nov 242.96
Nov 243.28
Nov 243.87
Oct 244.13
Price to Book
010203040med 12.67Aug 24Nov 24Mar 25Jun 25Oct 25Jan 26May 26
BLGO Price to Book by year
PeriodPrice to Book
May 2630.48
May 2630.72
Apr 2630.51
Apr 2629.37
Apr 2628.93
Apr 2630.07
Mar 2632.93
Mar 2633.49
Mar 2634.09
Mar 2633.41
Feb 2617.15
Feb 2616.3
Feb 2616.1
Feb 2616.91
Jan 2617.2
Jan 2617.78
Jan 2618.2
Jan 2618.72
Jan 2618.05
Dec 2516.84
Dec 2517.47
Dec 2516.83
Dec 2518.25
Nov 2517.5
Nov 2514.58
Nov 2515.04
Nov 259.12
Oct 257.83
Oct 258.25
Oct 258.26
Oct 258
Oct 258.27
Sep 258.98
Sep 2510.1
Sep 2510.71
Sep 2510.96
Aug 2510.95
Aug 259.91
Aug 258.85
Aug 259.94
Aug 2510.65
Jul 2511.2
Jul 2511.25
Jul 2511.86
Jul 2511.78
Jun 2511.6
Jun 2512.15
Jun 2511.84
Jun 2513.02
May 2512.63
May 2512.9
May 2512.72
May 2511.86
May 2511.07
Apr 2511.77
Apr 2511.54
Apr 2511.64
Apr 2512.5
Mar 2514.19
Mar 2514.57
Mar 2513.22
Mar 2513.26
Feb 2513.31
Feb 2513.3
Feb 2512.81
Feb 2513.56
Jan 2512.74
Jan 2512.67
Jan 2514.45
Jan 2515.01
Jan 2512.46
Dec 2410.04
Dec 249.8
Dec 249.8
Dec 249.81
Nov 249.92
Nov 249.01
Nov 249.16
Nov 249.35
Nov 2411.04
Oct 2411.78
Oct 2412.07
Oct 2412.17
Oct 2412.07
Sep 2412.07
Sep 2412.07
Sep 2412.23
Sep 2412.68
Aug 2412.33
Aug 2411.48
Aug 2412
Aug 2414.7
Aug 2414.66
Jul 2414.74
Jul 2414.76
Jul 2414.69
Jul 2414.77
Jun 2414.58
Jun 2415.69
Jun 2416.29
BioLargo, Inc.
BLGO
Stockpicker

Video analysis: BLGO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BLGO

BioLargo, Inc. (BLGO) Q2 2026 Earnings Call Transcript

seekingalpha.com · 11 Sep 2026

BioLargo, Inc. (BLGO) Q2 2026 Earnings Call Transcript

BioLargo, Inc. (BLGO) Q2 2026 Earnings Call Transcript

BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and More

accessnewswire.com · 10 Sep 2026

BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and More

Partnership backed by a conditional grant commitment from Emissions Reduction Alberta to in support of $4.6 CAD million project, with commercial trials already underway in northern Alberta WESTMINSTER, CA / ACCESS Newswire / September 10, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that it and its subsidiary BioLargo Canada have entered into a strategic partnership with Fort McKay Oil Services, a registered First-Nation company, combining the resources and leadership of the companies to deliver treatment solutions for oil sands process water (OSPW), wastewater and industrial solutions in the Athabasca region of northern Alberta utilizing BioLargo's advanced water treatment and industrial technologies. The new venture, Tũ Nipi Water Solutions Ltd.

BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern Time

accessnewswire.com · 9 Sep 2026

BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern Time

WESTMINSTER, CA / ACCESS Newswire / September 9, 2026 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host a townhall and investor webcast and conference call on Thursday, September 10th, 2026, at 1:00 pm Pacific / 4:00 pm Eastern. The event, which will be open to the public, will be held for an extended questions and answers session and to review the company's financial results for the three months ending June 30th, 2026, and discuss recent milestones.

BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution

accessnewswire.com · 3 Sep 2026

BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution

Agreement with Spartan Medical opens adds a channel to the U.S. government healthcare market, supplementing existing U.S. commercial distribution and 18 foreign countries. WESTMINSTER, CA / ACCESS Newswire / September 3, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences company, today announced that its subsidiary Clyra Medical Technologies is expanding distribution of its FDA-cleared ViaCLYR™ wound irrigation solution through a new Reseller Agreement with Spartan Medical Inc., opening a dedicated commercial channel to U.S. government healthcare facilities worldwide.

BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026

accessnewswire.com · 1 Sep 2026

BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026

WESTMINSTER, CA / ACCESS Newswire / September 1, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator and engineering services solution provider, today announced that Dennis P. Calvert, President and Chief Executive Officer, will participate in the inaugural Nasdaq / LD Micro Summit on Wednesday, September 9, 2026.

Critical Review: BioLargo (NASDAQ:BLGO) and Akzo Nobel (OTCMKTS:AKZOD)

defenseworld.net · 28 Aug 2026

Critical Review: BioLargo (NASDAQ:BLGO) and Akzo Nobel (OTCMKTS:AKZOD)

Profitability This table compares BioLargo and Akzo Nobel's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets BioLargo -11.45% -39.90% -22.06% Akzo Nobel 9.76% 9.43% 3.69% Earnings and Valuation This table compares BioLargo and Akzo Nobel"s gross revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio

BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York

accessnewswire.com · 25 Aug 2026

BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York

Former U.S. EPA senior executive Sally Gutierrez will represent BioLargo at the investor event. WESTMINSTER, CA / ACCESS Newswire / August 25, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences company, today announced that it will participate in Gabelli Funds' 4th Annual PFAS Symposium on September 24, 2026, in New York City.

Gabelli To Host 4th Annual PFAS Symposium

globenewswire.com · 24 Aug 2026

Gabelli To Host 4th Annual PFAS Symposium

PALM BEACH, Fla., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli is hosting its 4th Annual PFAS Symposium on September 24th, 2026, in New York City.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.